✦ LIBER ✦

Bloodtaking and Peacemaking: Feud, Law, and Society in Saga Icelandby William Ian Miller

✍ Scribed by Review by: Gísli Pálsson

Book ID: 124792151
Publisher: American Anthropological Association
Year: 1992
Tongue: English
Weight: 403 KB
Volume: 94
Category: Article
ISSN: 0002-7294
DOI: 10.2307/680593

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bloodtaking and Peacemaking: Feud, Law,

Bloodtaking and Peacemaking: Feud, Law, and Society in Saga Icelandby William Ian Miller

✍ Review by: David Koester 📂 Article 📅 1992 🏛 Duke University Press 🌐 English ⚖ 101 KB

Bloodtaking and Peacemaking: Feud, Law,

Bloodtaking and Peacemaking: Feud, Law, and Society in Saga Iceland. WILLIAM IAN MILLER

✍ GARY ALAN FINE 📂 Article 📅 1994 🏛 American Anthropological Association 🌐 English ⚖ 400 KB

Social/Cultural Anthropology: Bloodtakin

Social/Cultural Anthropology: Bloodtaking and Peacemaking: Feud, Law, and Society in Saga Iceland. William Ian Miller.

✍ Gísli Pálsson 📂 Article 📅 1992 🏛 American Anthropological Association 🌐 English ⚖ 198 KB

Law and Literature in Medieval Iceland:

Law and Literature in Medieval Iceland: Ljósvetninga saga and Valla-Ljóts sagaby Theodore M. Andersson; William Ian Miller

✍ Review by: Henry Ordower 📂 Article 📅 1991 🏛 University of Illinois Press 🌐 English ⚖ 271 KB

Role of Water in Electron-Initiated Proc

Role of Water in Electron-Initiated Processes and Radical Chemistry: Issues and Scientific Advances

✍ Garrett, Bruce C.; Dixon, David A.; Camaioni, Donald M.; Chipman, Daniel M.; Joh 📂 Article 📅 2005 🏛 American Chemical Society 🌐 English ⚖ 402 KB

A single infusion of zoledronic acid pro

A single infusion of zoledronic acid produces sustained remissions in paget disease: Data to 6.5 years

✍ Ian R Reid; Kenneth Lyles; Guoqin Su; Jacques P Brown; John P Walsh; Javier del 📂 Article 📅 2011 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 885 KB

## Abstract Two trials have shown that a single 5‐mg infusion of zoledronic acid achieves much higher response rates in Paget disease of bone than risedronate. The duration of this effect is unknown. We have conducted an open follow‐up of responders from the two trials (152 originally treated with